Mountain Valley MD Announces Appointment of New CFO
- None.
- None.
“I am very pleased to welcome Lucie Letellier to this important role and look forward to capitalizing on her leadership and expertise to support MVMD’s commercialization growth phase and the scaling of our operations,” said Dennis Hancock, President & CEO of the Company. “Ms. Letellier’s proven track record of results-driven leadership, strategic thinking and financial acumen comes at an important time for MVMD as we navigate complex international sales, royalty, and tax strategies.”
With a distinguished financial career spanning more-than 25 years, Ms.
“Ms.
The Company has granted stock options (the “Options”) to Ms.
The Company extends its appreciation to outgoing CFO Aaron Triplett for his extensive contributions to the Company’s development and providing financial leadership in a challenging start-up environment and wishes him well in his new endeavours.
ABOUT MOUNTAIN VALLEY MD HOLDINGS INC.
Mountain Valley MD is building a world-class organization centered around the implementation, licensing and reselling of key technologies and formulations:
- patented Quicksome™ oral formulation and delivery technologies,
- patented Quicksol™ solubility formulation technology
- licensed product reseller of Agrarius™, a novel agricultural plant signalling technology
Consistent with its vision towards “More Life”, MVMD applies its owned and licensed technologies to its work for advanced delivery of molecules for human and husbandry animal applications, including the development of products for pain management, weight loss, energy, focus, sleep, anxiety, and more. Additionally, MVMD’s work with Agrarius is focused on generating a positive impact on crop yields and reducing fertilizer usage.
MVMD’s patented Quicksome™ technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into highly efficient product formats. The result is a new generation of product formulations that could be capable of delivering nutraceutical and drug molecules into the body faster, with greater impact, efficiency and accuracy.
MVMD’s patented Quicksol™ technology covers all highly solubilized macrocyclic lactones that could be effectively applied in multiple viral applications that could positively impact human and animal health globally.
MVMD’s licensed Agrairus™ agricultural plant signalling technology that could be capable of application to agricultural crops to naturally increase yields, reduce fertilizer usage, and increase general resilience to pests and climate change.
For more Company information and contact details, visit www.MVMD.com.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
Certain statements contained in this news release may constitute forward-looking information. Forward-looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information.
The Company's actual results could differ materially from those anticipated in this forward-looking information as a result of regulatory decisions, competitive factors in the industries in which the Company operates, prevailing economic conditions, and other factors, many of which are beyond the control of the Company. The Company is making forward-looking statements, including but not limited to: The Company is making forward-looking statements including but not limited to: the effective date of the appointment of Ms.
Neither the CSE nor OTC has reviewed or approved the contents of this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230907704974/en/
For further information:
Dennis Hancock
President and Chief Executive Officer
Mountain Valley MD Holdings Inc.
Investor Relations @ 647-725-9755
Email: info@mvmd.com
www.MVMD.com
Source: Mountain Valley MD Holdings Inc.